-
Globus Medical earns FDA approval for non-fusion scoliosis system
Globus Medical recieved FDA aproval for its Reflect scoliosis correction system, the devicemaker said May 15. -
Waypoint Orthopedics earns FDA approval for spinal pedicle screw tool
Waypoint Orthopedics earned FDA approval for the Waypoint GPS, a bone awl for pedicle screw pilot hole drilling, the devicemaker said May 15. -
Stryker to lay off 500+ Florida employees
Stryker plans to lay off more than 500 employees by the end of December as it closes its Lakeland, Fla. facility, according to a WARN notice. -
Surgalign's Q1 revenue dips by $3.9M: 7 notes
Medical technology company Surgalign saw a $3.9 million dip in revenue in the first quarter of 2023 as compared with the same period last year, according to the company's first quarter financial report, released on May 11. -
NuVasive's Q1 sales grow 5.8 percent: 4 notes
NuVasive on May 10 posted first quarter sales of $307.7 million. -
Orthofix sees 65% revenue growth in Q1
Orthofix on May 9 posted $175.2 million in first quarter revenue. -
Intelivation Technologies launches minimally invasive screw system
Intelivation Technologies' Golden Isles minimally invasive screw system was launched, the devicemaker said May 9. -
Happe Spine's new interbody fusion system earns FDA nod
Happe Spine's Integrate-C interbody fusion system earned FDA 510(k) clearance, the devicemaker said May 8. -
Surgalign launches Holo AI Insights for neurovascular research
Surgalign launched Holo AI Insights for neurovascular research, the medtech company said May 8. -
Globus Medical's merger delayed: 3 earnings call notes
Globus Medical's planned merger with NuVasive will likely close in the third quarter of 2023 instead of mid-year, CEO Dan Scavilla said in a May 4 first quarter earnings call. -
Globus Medical sees 20% increase in Q1 sales: 4 notes
Globus Medical on May 4 posted first quarter sales of $276.7 million. -
OrthoPediatrics launches scoliosis system
OrthoPediatrics launched its Response Power system for scoliosis, the devicemaker said May 4. -
ZimVie sees 4.1% sales dip in Q1: 4 notes
ZimVie on May 3 posted net sales of $225.4 million in the first quarter of 2023. -
Stryker vs. Johnson & Johnson vs. Zimmer Biomet: How they compare in Q1 2023
Stryker, Johnson & Johnson and Zimmer Biomet posted their first quarter financial results for 2023, and data on their orthopedic sales. -
Dr. Hunaldo Villalobos debuts WatchTower spine navigation system
Hunaldo Villalobos, MD, performed the first U.S. case with Captiva Spine's WatchTower spine navigation system, the medtech company said May 2. -
Stryker completes acquisition of neurosurgery company
Stryker has acquired Cerus Endovascular, the devicemaker said May 2. -
Aurora Spine's fiscal year 2022 sales grow 41.1%: 4 notes
Aurora Spine on May 1 posted its results for the fourth quarter and full year of fiscal year 2022. -
Stryker's Q1 revenue hits $4.8B
Stryker's revenue in the first quarter of 2023 reached $4.8 billion, according to financial results posted May 1. -
Clinical study shows favorable outcomes for Amplify Surgical's DualPortal endoscopic technique
Amplify Surgical saw positive results in a clinical study for its DualPortal endoscopic technique. -
6 recent spine devices earning FDA nods
Here are six spine technologies earning FDA greenlights since March 1:
Page 25 of 198